Beta-Blocker Use during Pregnancy Correlates with Less Aortic Root Dilatation in Patients with Marfan's Syndrome

Background  Pregnant patients with Marfan's syndrome (MFS) are at an increased risk for adverse aortic outcomes. While beta-blockers are used to slow aortic root dilatation in nonpregnant MFS patients, the benefit of such therapy in pregnant MFS patients remains controversial. The purpose of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Emma A., Pistner, Andrew, Osobamiro, Oyinkansola, Banning, Stephanie, Shalhub, Sherene, Albright, Catherine, Horovitz, Ofir, Buber, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers, Inc. 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232026/
https://www.ncbi.nlm.nih.gov/pubmed/37055016
http://dx.doi.org/10.1055/a-2072-0469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232026/
https://www.ncbi.nlm.nih.gov/pubmed/37055016
http://dx.doi.org/10.1055/a-2072-0469

Ejemplares similares